Simon Coles - Vice President, Global Sales and Marketing
Simon's career spans two decades of consistent achievement in Healthcare Sales and Marketing, with Smith & Nephew, Baxter and Orteq. He has launched medical devices that have pioneered new treatments in the fields of biosurgery, wound care, orthobiologics and tissue regeneration. Operating at a global level he has worked extensively throughout Europe, Asia and the United States. Simon was Head of US Marketing from 2002-2005, helping to build the Baxter Biosurgery business to $125million revenue. His other role at Baxter was as Head of Global Marketing and Strategy with the Baxter Biosurgery unit. During this period at Baxter he was a member of the senior management team that created a new, global, direct sales franchise in surgery, with revenues of $260million, growing at 22% per annum. Since joining Orteq he has been responsible for the international launch and uptake of Actifit.
Joel Guidoux - Head of Regulatory and Clinical Affairs
Joël brings with him over 13 years of experience in international clinical development from the CRO (Innovex, Quintiles, PPD) and the Biotech (Genzyme) sectors, both with medicinal products and medical devices.
At Genzyme, Joël played an active role in the design and conduct of clinical trials leading to the registration of Synvisc One in Europe and the United-States, and subsequently worked in cartilage repair on a large European pivotal trial with autologous chondrocytes implantation.
Joël joined CellCoTec in August 2009 to take responsibility for clinical and global regulatory activities.